DExD/H-box RNA helicases as mediators of anti-viral innate immunity and essential host factors for viral replication

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1829, Issue 8, 2013, Pages 854-865

  Fullam, Anthony ^a   Schröder, Martina ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Anti viral immunity; Host factors; Innate immune signalling; Pattern recognition receptors; RNA helicases

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; DOUBLE STRANDED DNA; HOST FACTOR; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN DDX1; PROTEIN DDX3; PROTEIN DDX36; PROTEIN DDX41; PROTEIN DDX60; PROTEIN DHX9; RETINOIC ACID INDUCIBLE PROTEIN I; RNA HELICASE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UVOMORULIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; BINDING AFFINITY; CELL PROLIFERATION; CELL VIABILITY; CONFORMATIONAL TRANSITION; CPG ISLAND; CYTOKINE PRODUCTION; CYTOSOL; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HYDROLYSIS; INNATE IMMUNITY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; REVIEW; RNA BINDING; RNA METABOLISM; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS REPLICATION;

ANIMALS; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; RNA, VIRAL; VIRUS REPLICATION;

EID: 84878108881     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2013.03.012     Document Type: Review

References (173)

1. Caruthers J.M., McKay D.B. Helicase structure and mechanism. Curr. Opin. Struct. Biol. 2002, 12:123-133.
2. Cordin O., Banroques J., Tanner N.K., Linder P. The DEAD-box protein family of RNA helicases. Gene 2006, 367:17-37.
3. Hauk G., Bowman G.D. Structural insights into regulation and action of SWI2/SNF2 ATPases. Curr. Opin. Struct. Biol. 2011, 21:719-727.
4. Linder P., Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat. Rev. Mol. Cell Biol. 2011, 12:505-516.
5. Fuller-Pace F.V. DExD/H-box box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 2006, 34:4206-4215.
6. Medzhitov R., Janeway C. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 2000, 173:89-97.
7. Saito T., Gale M. Principles of intracellular viral recognition. Curr. Opin. Immunol. 2007, 19:17-23.
8. Thompson M.R., Kaminski J.J., Kurt-Jones E.A., Fitzgerald K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses 2011, 3:920-940.
9. Zhang Z., Yuan B., Lu N., Facchinetti V., Liu Y.-J. DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. J. Immunol. 2011, 187:4501-4508.
10. Zhang Z., Yuan B., Bao M., Lu N., Kim T., Liu Y.-J. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat. Immunol. 2011, 12:959-965.
11. Zhang Z., Kim T., Bao M., Facchinetti V., Jung Sung Y., Ghaffari Amir A., Qin J., Cheng G., Liu Y.-J. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011, 34:866-878.
12. Miyashita M., Oshiumi H., Matsumoto M., Seya T. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol. Cell. Biol. 2011, 31:3802-3819.
13. Oshiumi H., Sakai K., Matsumoto M., Seya T. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur. J. Immunol. 2010, 40:940-948.
14. Kim T., Pazhoor S., Bao M., Zhang Z., Hanabuchi S., Facchinetti V., Bover L., Plumas J., Chaperot L., Qin J., Liu Y.-J. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. 2010, 107:15181-15186.
15. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011, 1:519-525.
16. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 2000, 13:539-548.
17. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
18. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
19. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., Sirois C.M., Jin T., Latz E., Xiao T.S., Fitzgerald K.A., Paludan S.R., Bowie A.G. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 2010, 11:997-1004.
20. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007, 448:501-505.
21. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., Uematsu S., Kawai T., Takeuchi O., Akira S. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 2006, 7:40-48.
22. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., Akira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 2002, 169:6668-6672.
23. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
24. Seth R.B., Sun L., Ea C.K., Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005, 122:669-682.
25. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 2005, 19:727-740.
26. Ishikawa H., Barber G.N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008, 455:674-678.
27. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., Terai K., Matsuda M., Inoue J., Uematsu S., Takeuchi O., Akira S. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 2004, 5:1061-1068.
28. Hoshino K., Sugiyama T., Matsumoto M., Tanaka T., Saito M., Hemmi H., Ohara O., Akira S., Kaisho T. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 2006, 440:949-953.
29. Izaguirre A., Barnes B.J., Amrute S., Yeow W.S., Megjugorac N., Dai J., Feng D., Chung E., Pitha P.M., Fitzgerald-Bocarsly P. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 2003, 74:1125-1138.
30. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2:675-687.
31. Weber F., Kochs G., Haller O. Inverse interference: how viruses fight the interferon system. Viral Immunol. 2004, 17:498-515.
32. Leung D.W., Basler C.F., Amarasinghe G.K. Molecular mechanisms of viral inhibitors of RIG-I-like receptors. Trends Microbiol. 2012, 20:139-146.
33. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8:911-922.
34. Schmidt A., Rothenfusser S., Hopfner K.-P. Sensing of viral nucleic acids by RIG-I: from translocation to translation. Eur. J. Cell Biol. 2012, 91:78-85.
35. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale M., Akira S., Yonehara S., Kato A., Fujita T. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 2005, 175:2851-2858.
36. Takahasi K., Kumeta H., Tsuduki N., Narita R., Shigemoto T., Hirai R., Yoneyama M., Horiuchi M., Ogura K., Fujita T., Inagaki F. Solution structures of cytosolic RNA sensor MDA5 and LGP2 C-terminal domains: identification of the RNA recognition loop in RIG-I-like receptors. J. Biol. Chem. 2009, 284:17465-17474.
37. Cui S., Eisenacher K., Kirchhofer A., Brzozka K., Lammens A., Lammens K., Fujita T., Conzelmann K.K., Krug A., Hopfner K.P. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol. Cell 2008, 29:169-179.
38. Schlee M., Roth A., Hornung V., Hagmann C.A., Wimmenauer V., Barchet W., Coch C., Janke M., Mihailovic A., Wardle G., Juranek S., Kato H., Kawai T., Poeck H., Fitzgerald K.A., Takeuchi O., Akira S., Tuschl T., Latz E., Ludwig J., Hartmann G. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 2009, 31:25-34.
39. Baum A., Sachidanandam R., Garcia-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16303-16308.
40. Rehwinkel J., Tan C.P., Goubau D., Schulz O., Pichlmair A., Bier K., Robb N., Vreede F., Barclay W., Fodor E., Sousa C.Reis e RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 2010, 140:397-408.
41. Vela A., Fedorova O., Ding S.C., Pyle A.M. The thermodynamic basis for viral RNA detection by the RIG-I innate immune sensor. J. Biol. Chem. 2012.
42. Kowalinski E., Lunardi T., McCarthy Andrew A., Louber J., Brunel J., Grigorov B., Gerlier D., Cusack S. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by Viral RNA. Cell 2011, 147:423-435.
43. D. Luo, A. Kohlway, A. Vela, Anna M. Pyle, Visualizing the Determinants of Viral RNA Recognition by Innate Immune Sensor RIG-I, Structure.
44. Gee P., Chua P.K., Gevorkyan J., Klumpp K., Najera I., Swinney D.C., Deval J. Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J. Biol. Chem. 2008, 283:9488-9496.
45. Leung D.W., Amarasinghe G.K. Structural insights into RNA recognition and activation of RIG-I-like receptors. Curr. Opin. Struct. Biol. 2012, 22:297-303.
46. F. Ferrage, K. Dutta, E. Nistal-Villán, Jenish R. Patel, María T. Sánchez-Aparicio, P. De Ioannes, A. Buku, Gloria G. Aseguinolaza, A. García-Sastre, Aneel K. Aggarwal, Structure and Dynamics of the Second CARD of Human RIG-I Provide Mechanistic Insights into Regulation of RIG-I Activation, Structure.
47. Binder M., Eberle F., Seitz S., Mücke N., Hüber C.M., Kiani N., Kaderali L., Lohmann V., Dalpke A., Bartenschlager R. Molecular mechanism of signal perception and integration by the innate immune sensor retinoic acid-inducible gene-I (RIG-I). J. Biol. Chem. 2011, 286:27278-27287.
48. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
49. Takahasi K., Yoneyama M., Nishihori T., Hirai R., Kumeta H., Narita R., Gale M., Inagaki F., Fujita T. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol. Cell 2008, 29:428-440.
50. Wang Y., Ludwig J., Schuberth C., Goldeck M., Schlee M., Li H., Juranek S., Sheng G., Micura R., Tuschl T., Hartmann G., Patel D.J. Structural and functional insights into 5[prime]-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol. 2010, 17:781-787.
51. Myong S., Cui S., Cornish P.V., Kirchhofer A., Gack M.U., Jung J.U., Hopfner K.-P., Ha T. Cytosolic viral sensor RIG-I Is a 5'-triphosphate-dependent translocase on double-stranded RNA. Science 2009, 323:1070-1074.
52. Jiang F., Ramanathan A., Miller M.T., Tang G.-Q., Gale M., Patel S.S., Marcotrigiano J. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
53. Jiang X., Kinch L.N., Brautigam Chad A., Chen X., Du F., Grishin N.V., Chen Zhijian J. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
54. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
55. Liu H.M., Loo Y.M., Horner S.M., Zornetzer G.A., Katze M.G., Gale M. The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 2012, 11:528.
56. Castanier C., Garcin D., Vazquez A., Arnoult D. Mitochondrial dynamics regulate the RIG-I-like receptor antiviral pathway. EMBO Rep. 2010, 11:133-138.
57. Onoguchi K., Onomoto K., Takamatsu S., Jogi M., Takemura A., Morimoto S., Julkunen I., Namiki H., Yoneyama M., Fujita T. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog. 2010, 6:e1001012.
58. Horner S.M., Liu H.M., Park H.S., Briley J., Gale M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:14590-14595.
59. van Zuylen W.J., Doyon P., Clément J.-F., Khan K.A., D'Ambrosio L.M., DÔ F., St-Amant-Verret M., Wissanji T., Emery G., Gingras A.-C., Meloche S., Servant M.J. Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-golgi transport compartments in innate immunity. PLoS Pathog. 2012, 8:e1002747.
60. Oganesyan G., Saha S.K., Guo B., He J.Q., Shahangian A., Zarnegar B., Perry A., Cheng G. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006, 439:208-211.
61. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., Hiiragi A., Dermody T.S., Fujita T., Akira S., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Sousa C.Reis e, Matsuura Y. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. J. Exp. Med. 2008, 205:1601-1610.
62. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., Yamaguchi O., Otsu K., Tsujimura T., Koh C.S., Sousa C.Reis e, Matsuura Y., Fujita T., Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105.
63. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., Akira S., Gill M.A., Garcia-Sastre A., Katze M.G., Gale M. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 2008, 82:335-345.
64. McCartney S.A., Thackray L.B., Gitlin L., Gilfillan S., Virgin H.W., Colonna M. MDA-5 recognition of a murine norovirus. PLoS Pathog. 2008, 4:e1000108.
65. Delaloye J., Roger T., Steiner-Tardivel Q.-G., Le Roy D., Knaup Reymond M., Akira S., Petrilli V., Gomez C.E., Perdiguero B., Tschopp J., Pantaleo G., Esteban M., Calandra T. Innate immune sensing of modified vaccinia virus ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog. 2009, 5:e1000480.
66. Pichlmair A., Schulz O., Tan C.-P., Rehwinkel J., Kato H., Takeuchi O., Akira S., Way M., Schiavo G., Sousa C.Reis e Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 2009, 83:10761-10769.
67. Li X., Lu C., Stewart M., Xu H., Strong R.K., Igumenova T., Li P. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch. Biochem. Biophys. 2009, 488:23-33.
68. Li X., Ranjith-Kumar C.T., Brooks M.T., Dharmaiah S., Herr A.B., Kao C., Li P. The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J. Biol. Chem. 2009, 284:13881-13891.
69. Saito T., Hirai R., Loo Y.-M., Owen D., Johnson C.L., Sinha S.C., Akira S., Fujita T., Gale M. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. 2007, 104:582-587.
70. Berke I.C., Modis Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 2012, 31:1714-1726.
71. Berke I.C., Yu X., Modis Y., Egelman E.H. MDA5 assembles into a polar helical filament on dsRNA. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:18437-18441.
72. Peisley A., Lin C., Wu B., Orme-Johnson M., Liu M., Walz T., Hur S. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc. Natl. Acad. Sci. 2011, 108:21010-21015.
73. Rothenfusser S., Goutagny N., DiPerna G., Gong M., Monks B.G., Schoenemeyer A., Yamamoto M., Akira S., Fitzgerald K.A. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 2005, 175:5260-5268.
74. Venkataraman T., Valdes M., Elsby R., Kakuta S., Caceres G., Saijo S., Iwakura Y., Barber G.N. Loss of DExD/H-box box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 2007, 178:6444-6455.
75. Satoh T., Kato H., Kumagai Y., Yoneyama M., Sato S., Matsushita K., Tsujimura T., Fujita T., Akira S., Takeuchi O. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc. Natl. Acad. Sci. 2010, 107:1512-1517.
76. Pollpeter D., Komuro A., Barber G.N., Horvath C.M. Impaired cellular responses to cytosolic DNA or infection with Listeria monocytogenes and vaccinia virus in the absence of the murine LGP2 protein. PLoS One 2011, 6:e18842.
77. Malur M., Gale M., Krug R.M. LGP2 downregulates interferon production during infection with seasonal human influenza a viruses that activate interferon regulatory factor 3. J. Virol. 2012, 86:10733-10738.
78. Bruns A.M., Pollpeter D., Hadizadeh N., Myong S., Marko J.F., Horvath C.M. ATP hydrolysis enhances RNA recognition and antiviral signal transduction by the innate immune sensor, laboratory of genetics and physiology 2 (LGP2). J. Biol. Chem. 2013, 288:938-946.
79. Lahn B.T., Page D.C. Functional coherence of the human Y chromosome. Science 1997, 278:675-680.
80. Ditton H.J., Zimmer J., Kamp C., Rajpert-De Meyts E., Vogt P.H. The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control. Hum. Mol. Genet. 2004, 13:2333-2341.
81. Schröder M. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem. Pharmacol. 2010, 79:297-306.
82. Chao C.H., Chen C.M., Cheng P.L., Shih J.W., Tsou A.P., Lee Y.H. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 2006, 66:6579-6588.
83. Botlagunta M., Vesuna F., Mironchik Y., Raman A., Lisok A., Winnard P., Mukadam S., Van Diest P., Chen J.H., Farabaugh P., Patel A.H., Raman V. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 2008, 11:11.
84. Soulat D., Burckstummer T., Westermayer S., Goncalves A., Bauch A., Stefanovic A., Hantschel O., Bennett K.L., Decker T., Superti-Furga G. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 2008, 26:26.
85. Lai M.-C., Chang W.-C., Shieh S.-Y., Tarn W.-Y. DDX3 regulates cell growth through translational control of cyclin E1. Mol. Cell. Biol. 2010, 30:5444-5453.
86. Soto-Rifo R., Rubilar P.S., Limousin T., de Breyne S., Decimo D., Ohlmann T. DEAD-box protein DDX3 associates with eIF4F to promote translation of selected mRNAs. EMBO J. 2012, 31:3745-3756.
87. Schroder M., Baran M., Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKK-epsilon-mediated IRF activation. EMBO J. 2008, 17:17.
88. Oshiumi H., Ikeda M., Matsumoto M., Watanabe A., Takeuchi O., Akira S., Kato N., Shimotohno K., Seya T. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction. PLoS One 2010, 5:e14258.
89. Kang J.I., Kwon Y.C., Ahn B.Y. Modulation of the type I interferon pathways by culture-adaptive hepatitis C virus core mutants. FEBS Lett. 2012, 586:1272-1278.
90. Randall G., Panis M., Cooper J.D., Tellinghuisen T.L., Sukhodolets K.E., Pfeffer S., Landthaler M., Landgraf P., Kan S., Lindenbach B.D., Chien M., Weir D.B., Russo J.J., Ju J., Brownstein M.J., Sheridan R., Sander C., Zavolan M., Tuschl T., Rice C.M. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. 2007, 104:12884-12889.
91. Ariumi Y., Kuroki M., Abe K., Dansako H., Ikeda M., Wakita T., Kato N. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J. Virol. 2007, 81:13922-13926.
92. Wang H., Kim S., Ryu W.S. DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids. J. Virol. 2009, 83:5815-5824.
93. Wang H., Ryu W.-S. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 2010, 6:e1000986.
94. Yu S., Chen J., Wu M., Chen H., Kato N., Yuan Z. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKK{epsilon} and DDX3. J. Gen. Virol. 2010, 91:2080-2090.
95. DeFilippis V.R., Alvarado D., Sali T., Rothenburg S., Fruh K. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J. Virol. 2010, 84:585-598.
96. Gu L., Fullam A., Brennan R., Schröder M. The human DEAD-box helicase 3 couples IKK-epsilon to IRF3 activation. Mol. Cell. Biol. 2013, 1:32.
97. Keating S.E., Baran M., Bowie A.G. Cytosolic DNA sensors regulating type I interferon induction. Trends Immunol. 2011, 32:574-581.
98. Barber G.N. Cytoplasmic DNA innate immune pathways. Immunol. Rev. 2011, 243:99-108.
99. Stein S.C., Falck-Pedersen E. Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 Cells. J. Virol. 2012, 86:4527-4537.
100. Schroder K., Muruve D.A., Tschopp J. Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr. Biol. 2009, 19:R262-265.
101. Parvatiyar K., Zhang Z., Teles R.M., Ouyang S., Jiang Y., Iyer S.S., Zaver S.A., Schenk M., Zeng S., Zhong W., Liu Z.J., Modlin R.L., Liu Y.J., Cheng G. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 2012.
102. Burdette D.L., Monroe K.M., Sotelo-Troha K., Iwig J.S., Eckert B., Hyodo M., Hayakawa Y., Vance R.E. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011, 478:515-518.
103. Wu J., Sun L., Chen X., Du F., Shi H., Chen C., Chen Z.J. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
104. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
105. Abdul-Ghani M., Hartman K.L., Ngsee J.K. Abstrakt interacts with and regulates the expression of sorting nexin-2. J. Cell. Physiol. 2005, 204:210-218.
106. Griffin C.T., Trejo J., Magnuson T. Genetic evidence for a mammalian retromer complex containing sorting nexins 1 and 2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15173-15177.
107. Prosser D.C., Tran D., Schooley A., Wendland B., Ngsee J.K. A novel, retromer-independent role for sorting nexins 1 and 2 in RhoG-dependent membrane remodeling. Traffic 2010, 11:1347-1362.
108. Saitoh T., Fujita N., Hayashi T., Takahara K., Satoh T., Lee H., Matsunaga K., Kageyama S., Omori H., Noda T., Yamamoto N., Kawai T., Ishii K., Takeuchi O., Yoshimori T., Akira S. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc. Natl. Acad. Sci. 2009, 106:20842-20846.
109. Sadler A.J., Latchoumanin O., Hawkes D., Mak J., Williams B.R.G. An antiviral response directed by PKR phosphorylation of the RNA helicase A. PLoS Pathog. 2009, 5:e1000311.
110. Fuchsová B., Novák P., Kafková J., Hozák P. Nuclear DNA helicase II is recruited to IFN-α-activated transcription sites at PML nuclear bodies. J. Cell Biol. 2002, 158:463-473.
111. Bleoo S., Sun X., Hendzel M.J., Rowe J.M., Packer M., Godbout R. Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA. Mol. Biol. Cell 2001, 12:3046-3059.
112. Chen H.C., Lin W.C., Tsay Y.G., Lee S.C., Chang C.J. An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K. J. Biol. Chem. 2002, 277:40403-40409.
113. Ishaq M., Ma L., Wu X., Mu Y., Pan J.a., Hu J., Hu T., Fu Q., Guo D. The DEAD-box RNA helicase DDX1 interacts with RelA and enhances nuclear factor kappaB-mediated transcription. J. Cell. Biochem. 2009, 106:296-305.
114. Henning D., So R.B., Jin R., Lau L.F., Valdez B.C. Silencing of RNA Helicase II/Guα inhibits mammalian ribosomal RNA production. J. Biol. Chem. 2003, 278:52307-52314.
115. Holmström T.H., Mialon A., Kallio M., Nymalm Y., Mannermaa L., Holm T., Johansson H., Black E., Gillespie D., Salminen T.A., Langel Ü., Valdez B.C., Westermarck J. c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21. J. Biol. Chem. 2008, 283:7046-7053.
116. Westermarck J., Weiss C., Saffrich R., Kast J., Musti A.M., Wessely M., Ansorge W., Seraphin B., Wilm M., Valdez B.C., Bohmann D. The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription. EMBO J. 2002, 21:451-460.
117. Chalupníková K., Lattmann S., Selak N., Iwamoto F., Fujiki Y., Nagamine Y. Recruitment of the RNA helicase RHAU to stress granules via a unique RNA-binding domain. J. Biol. Chem. 2008, 283:35186-35198.
118. Tran H., Schilling M., Wirbelauer C., Hess D., Nagamine Y. Facilitation of mRNA deadenylation and decay by the exosome-bound, DExH protein RHAU. Mol. Cell 2004, 13:101-111.
119. Lattmann S., Giri B., Vaughn J.P., Akman S.A., Nagamine Y. Role of the amino terminal RHAU-specific motif in the recognition and resolution of guanine quadruplex-RNA by the DEAH-box RNA helicase RHAU. Nucleic Acids Res. 2010, 38:6219-6233.
120. Vaughn J.P., Creacy S.D., Routh E.D., Joyner-Butt C., Jenkins G.S., Pauli S., Nagamine Y., Akman S.A. The DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4-DNA resolving activity in hela cell lysates. J. Biol. Chem. 2005, 280:38117-38120.
121. Tornaletti S., Park-Snyder S., Hanawalt P.C. G4-forming sequences in the non-transcribed DNA strand pose blocks to T7 RNA polymerase and mammalian RNA polymerase II. J. Biol. Chem. 2008, 283:12756-12762.
122. Huang W., Smaldino P.J., Zhang Q., Miller L.D., Cao P., Stadelman K., Wan M., Giri B., Lei M., Nagamine Y., Vaughn J.P., Akman S.A., Sui G. Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Res. 2012, 40:1033-1049.
123. Siednienko J., Maratha A., Yang S., Mitkiewicz M., Miggin S.M., Moynagh P.N. Nuclear factor κB subunits RelB and cRel negatively regulate toll-like receptor 3-mediated β-interferon production via induction of transcriptional repressor protein YY1. J. Biol. Chem. 2011, 286:44750-44763.
124. Krug A., Rothenfusser S., Hornung V., Jahrsdorfer B., Blackwell S., Ballas Z.K., Endres S., Krieg A.M., Hartmann G. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 2001, 31:2154-2163.
125. Hartmann G., Weeratna R.D., Ballas Z.K., Payette P., Blackwell S., Suparto I., Rasmussen W.L., Waldschmidt M., Sajuthi D., Purcell R.H., Davis H.L., Krieg A.M. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J. Immunol. 2000, 164:1617-1624.
126. Zhang S., Grosse F. Nuclear DNA helicase II unwinds both DNA and RNA. Biochemistry 1994, 33:3906-3912.
127. Jain A., Bacolla A., Chakraborty P., Grosse F., Vasquez K.M. Human DHX9 helicase unwinds triple-helical DNA structures. Biochemistry 2010, 49:6992-6999.
128. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
129. Ranji A., Boris-Lawrie K. RNA helicases: emerging roles in viral replication and the host innate response. RNA Biol. 2010, 7:775-787.
130. Lorgeoux R.P., Guo F., Liang C. From promoting to inhibiting: diverse roles of helicases in HIV-1 replication. Retrovirology 2012, 9:79.
131. Yedavalli V.S., Neuveut C., Chi Y.H., Kleiman L., Jeang K.T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004, 119:381-392.
132. Daelemans D., Afonina E., Nilsson J., Werner G., Kjems J., De Clercq E., Pavlakis G.N., Vandamme A.-M. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14440-14445.
133. Ishaq M., Hu J., Wu X., Fu Q., Yang Y., Liu Q., Guo D. Knockdown of cellular RNA helicase DDX3 by short hairpin RNAs suppresses HIV-1 viral replication without inducing apoptosis. Mol. Biotechnol. 2008, 39:231-238.
134. Yedavalli V.S., Zhang N., Cai H., Zhang P., Starost M.F., Hosmane R.S., Jeang K.T. Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication. J. Med. Chem. 2008, 51:5043-5051.
135. Maga G., Falchi F., Garbelli A., Belfiore A., Witvrouw M., Manetti F., Botta M. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3. J. Med. Chem. 2008, 51:6635-6638.
136. Maga G., Falchi F., Radi M., Botta L., Casaluce G., Bernardini M., Irannejad H., Manetti F., Garbelli A., Samuele A., Zanoli S., Este J.A., Gonzalez E., Zucca E., Paolucci S., Baldanti F., De Rijck J., Debyser Z., Botta M. Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation. ChemMedChem 2011, 6:1371-1389.
137. Radi M., Falchi F., Garbelli A., Samuele A., Bernardo V., Paolucci S., Baldanti F., Schenone S., Manetti F., Maga G., Botta M. Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors. Bioorg. Med. Chem. Lett. 2012, 22:2094-2098.
138. Mamiya N., Worman H.J. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 1999, 274:15751-15756.
139. Owsianka A.M., Patel A.H. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 1999, 257:330-340.
140. You L.-R., Chen C.-M., Yeh T.-S., Tsai T.-Y., Mai R.-T., Lin C.-H., Lee Y.-H.W. Hepatitis C virus core protein interacts with cellular putative RNA helicase. J. Virol. 1999, 73:2841-2853.
141. Angus A.G.N., Dalrymple D., Boulant S., McGivern D.R., Clayton R.F., Scott M.J., Adair R., Graham S., Owsianka A.M., Targett-Adams P., Li K., Wakita T., McLauchlan J., Lemon S.M., Patel A.H. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J. Gen. Virol. 2010, 91:122-132.
142. Sun C., Pager C.T., Luo G., Sarnow P., Cate J.H.D. Hepatitis C virus core-derived peptides inhibit genotype 1b viral genome replication via interaction with DDX3X. PLoS One 2010, 5:e12826.
143. Chang P.C., Chi C.W., Chau G.Y., Li F.Y., Tsai Y.H., Wu J.C., Lee Y.H.Wu. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2005, 25:1991-2003.
144. Buhler S., Bartenschlager R. Promotion of hepatocellular carcinoma by hepatitis C virus. Dig. Dis. 2012, 30:445-452.
145. Vashist S., Urena L., Chaudhry Y., Goodfellow I. Identification of RNA-protein interaction networks involved in the norovirus life cycle. J. Virol. 2012, 86:11977-11990.
146. H.S. Chahar, S. Chen, N. Manjunath, P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication, Virology.
147. Fang J., Kubota S., Yang B., Zhou N., Zhang H., Godbout R., Pomerantz R.J. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004, 330:471-480.
148. Robertson-Anderson R.M., Wang J., Edgcomb S.P., Carmel A.B., Williamson J.R., Millar D.P. Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element. J. Mol. Biol. 2011, 410:959-971.
149. Edgcomb S.P., Carmel A.B., Naji S., Ambrus-Aikelin G., Reyes J.R., Saphire A.C.S., Gerace L., Williamson J.R. DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication. J. Mol. Biol. 2012, 415:61-74.
150. Sunden Y., Semba S., Suzuki T., Okada Y., Orba Y., Nagashima K., Umemura T., Sawa H. DDX1 promotes proliferation of the JC virus through transactivation of its promoter. Microbiol. Immunol. 2007, 51:339-347.
151. Sunden Y., Semba S., Suzuki T., Okada Y., Orba Y., Nagashima K., Umemura T., Sawa H. Identification of DDX1 as a JC virus transcriptional control region-binding protein. Microbiol. Immunol. 2007, 51:327-337.
152. Xu L., Khadijah S., Fang S., Wang L., Tay F.P.L., Liu D.X. The cellular RNA helicase DDX1 interacts with coronavirus nonstructural protein 14 and enhances viral replication. J. Virol. 2010, 84:8571-8583.
153. Minskaia E., Hertzig T., Gorbalenya A.E., Campanacci V., Cambillau C., Canard B., Ziebuhr J. Discovery of an RNA virus 3'→5' exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5108-5113.
154. Tingting P., Caiyun F., Zhigang Y., Pengyuan Y., Zhenghong Y. Subproteomic analysis of the cellular proteins associated with the 3' untranslated region of the hepatitis C virus genome in human liver cells. Biochem. Biophys. Res. Commun. 2006, 347:683-691.
155. Schütz P., Wahlberg E., Karlberg T., Hammarström M., Collins R., Flores A., Schüler H. Crystal structure of human RNA Helicase A (DHX9): structural basis for unselective nucleotide base binding in a DEAD-box variant protein. J. Mol. Biol. 2010, 400:768-782.
156. Li J., Tang H., Mullen T.-M., Westberg C., Reddy T.R., Rose D.W., Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl. Acad. Sci. 1999, 96:709-714.
157. Fujii R., Okamoto M., Aratani S., Oishi T., Ohshima T., Taira K., Baba M., Fukamizu A., Nakajima T. A Role of RNA Helicase A in cis-acting transactivation response element-mediated transcriptional regulation of human immunodeficiency virus type 1. J. Biol. Chem. 2001, 276:5445-5451.
158. Li J., Tang H., Mullen T.M., Westberg C., Reddy T.R., Rose D.W., Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:709-714.
159. Reddy T.R., Tang H., Xu W., Wong-Staal F. Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA. Oncogene 2000, 19:3570-3575.
160. Bolinger C., Sharma A., Singh D., Yu L., Boris-Lawrie K. RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions. Nucleic Acids Res. 2010, 38:1686-1696.
161. Roy B.B., Hu J., Guo X., Russell R.S., Guo F., Kleiman L., Liang C. Association of RNA Helicase A with human immunodeficiency virus type 1 particles. J. Biol. Chem. 2006, 281:12625-12635.
162. Xing L., Liang C., Kleiman L. Coordinate roles of gag and RNA Helicase A in promoting the annealing of to HIV-1 RNA. J. Virol. 2011, 85:1847-1860.
163. Liu J., Henao-Mejia J., Liu H., Zhao Y., He J.J. Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3. J. Neuroimmune Pharmacol. 2011, 6:308-321.
164. SenGupta D.N., Berkhout B., Gatignol A., Zhou A.M., Silverman R.H. Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:7492-7496.
165. Bolinger C., Yilmaz A., Hartman T.R., Kovacic M.B., Fernandez S., Ye J., Forget M., Green P.L., Boris-Lawrie K. RNA helicase A interacts with divergent lymphotropic retroviruses and promotes translation of human T-cell leukemia virus type 1. Nucleic Acids Res. 2007, 35:2629-2642.
166. Lawrence P., Rieder E. Identification of RNA helicase a as a new host factor in the replication cycle of foot-and-mouth disease virus. J. Virol. 2009, 83:11356-11366.
167. Isken O., Baroth M., Grassmann C.W., Weinlich S., Ostareck D.H., Ostareck-Lederer A., Behrens S.E. Nuclear factors are involved in hepatitis C virus RNA replication. RNA 2007, 13:1675-1692.
168. Lin L., Li Y., Pyo H.-M., Lu X., Raman S.N.T., Liu Q., Brown E.G., Zhou Y. Identification of RNA helicase A as a cellular factor that interacts with influenza a virus NS1 protein and its role in the virus life cycle. J. Virol. 2012, 86:1942-1954.
169. Naji S., Ambrus G., Cimermančič P., Reyes J.R., Johnson J.R., Filbrandt R., Huber M.D., Vesely P., Krogan N.J., Yates J.R., Saphire A.C., Gerace L. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol. Cell. Proteomics 2012, 11:111.
170. Jangra R.K., Yi M., Lemon S.M. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J. Virol. 2010, 84:6810-6824.
171. Yu S.F., Lujan P., Jackson D.L., Emerman M., Linial M.L. The DEAD-box RNA helicase DDX6 is required for efficient encapsidation of a retroviral genome. PLoS Pathog. 2011, 7:e1002303.
172. Chahar H.S., Chen S., Manjunath N. P-body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication. Virology 2012.
173. Reed J.C., Molter B., Geary C.D., McNevin J., McElrath J., Giri S., Klein K.C., Lingappa J.R. HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly. J. Cell Biol. 2012, 198:439-456.